BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18060715)

  • 1. Assessment of three different software systems in the evaluation of dynamic MRI of the breast.
    Kurz KD; Steinhaus D; Klar V; Cohnen M; Wittsack HJ; Saleh A; Mödder U; Blondin D
    Eur J Radiol; 2009 Feb; 69(2):300-7. PubMed ID: 18060715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angle between 1 and 4 min gives the most significant difference in time-intensity curves between benign disease and breast cancer: analysis of dynamic magnetic resonance imaging in 103 patients with breast lesions.
    Hara M; Watanabe T; Okumura A; Kato K; Mohri N; Ishikawa M; Mizuno A; Takeyama H
    Clin Imaging; 2009; 33(5):335-42. PubMed ID: 19712811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of breast cancer types by texture analysis of magnetic resonance images.
    Holli K; Lääperi AL; Harrison L; Luukkaala T; Toivonen T; Ryymin P; Dastidar P; Soimakallio S; Eskola H
    Acad Radiol; 2010 Feb; 17(2):135-41. PubMed ID: 19945302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical shift MRI: is there any contribution to morphologic evaluation of solid breast masses?
    Gokalp G; Topal U; Bolca N; Ercan I
    Acad Radiol; 2009 Oct; 16(10):1263-71. PubMed ID: 19608436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions?
    Ballesio L; Savelli S; Angeletti M; Porfiri LM; D'Ambrosio I; Maggi C; Castro ED; Bennati P; Fanelli GP; Vestri AR; Manganaro L
    Eur J Radiol; 2009 Jul; 71(1):96-101. PubMed ID: 18479866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis?
    Baltzer PA; Renz DM; Kullnig PE; Gajda M; Camara O; Kaiser WA
    Acad Radiol; 2009 Apr; 16(4):435-42. PubMed ID: 19268855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
    Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
    Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
    Sadowski EA; Kelcz F
    J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typical atypical findings on dynamic MRI of the breast.
    Kurz KD; Roy S; Mödder U; Skaane P; Saleh A
    Eur J Radiol; 2010 Nov; 76(2):195-210. PubMed ID: 19726148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.